Humber River Regional Hospital
Weston, Ontario M9N 1N8
0 studies enrolling now · 15 studies all time
What they study most
Breast Cancer, Chronic Kidney Disease, Chronic Renal Failure, Chronic Renal Insufficiency, Colorectal Cancer, Lung Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Non Small Cell Lung Cancer, Non-small Cell Lung Cancer, Ovarian Cancer, Pulmonary Embolism, Sarcoma
Studies at this site
- Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer — Completed
- BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early
- Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer — Completed
- Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma — Completed
- Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer — Completed
- ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer — Completed
- Combination Chemotherapy in Treating Patients With Multiple Myeloma — Completed
- Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma — Completed
- Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer — Completed
- AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy — Completed
- Genetic Study in Patients With Stage II or Stage III Colon Cancer — Completed
- Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy — Completed
- Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease — Completed
- Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer — Completed
- SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism — Completed